Therapeutics News
-
India suggests use of asthma drug to block crucial SARS-CoV-2 protein
Therapeutics | News | 0 Comment | 27 Apr, 2022
A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2, and ...Read more
-
Startups accelerate cell therapy development for solid tumours in China
Therapeutics | News | 0 Comment | 25 Apr, 2022
China-based startups Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine have announced a long-term strateg...Read more
-
Australia provides grant worth $4 M for stroke and kidney disease research
Therapeutics | News | 0 Comment | 25 Apr, 2022
More than $4 million has been awarded to two projects at The George Institute for Global Health at UNSW Sydney, Australi...Read more
-
Singapore launches research centre to advance biomedical research with data analytics, AI
Therapeutics | News | 0 Comment | 25 Apr, 2022
Nanyang Technological University, Singapore (NTU Singapore)’s Lee Kong Chian School of Medicine has launched a res...Read more
-
Singapore makes further advancement in cancer nanomedicine
Therapeutics | News | 0 Comment | 21 Apr, 2022
A study led by researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), in c...Read more
-
Singapore aims to develop novel treatments for tackling osteoarthritis
Therapeutics | News | 1 Comment | 20 Apr, 2022
Scientists at Nanyang Technological University, Singapore (NTU Singapore) are aiming to develop novel treatments to tack...Read more
-
AI-driven Israeli company Embryonics partners with Indian Fertility Centre
Therapeutics | News | 0 Comment | 20 Apr, 2022
Israel-based data-driven fertility company Embryonics announced its first collaboration in India with Jaslok-FertilTree ...Read more
-
Australia explores risk reduction of stroke and heart problems after surgery
Therapeutics | News | 0 Comment | 18 Apr, 2022
Researchers from the University of Sydney and Westmead Hospital in Australia have been awarded $1.8 million to advance r...Read more
-
Stroke cuts life expectancy by one third: Australian study
Therapeutics | News | 1 Comment | 15 Apr, 2022
Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, promptin...Read more
-
Therapeutics | News | 0 Comment | 13 Apr, 2022
Juniper Biologics, a Singapore-based science-led healthcare company, has gained the licensing rights to develop and...Read more
-
Australia develops wireless neuro-stimulator to revolutionise patient care
Therapeutics | News | 0 Comment | 12 Apr, 2022
Many neurological disorders like Parkinson’s, chronic depression and other psychiatric conditions could be managed...Read more
-
Australia finds antimicrobial resistance making UTIs more deadly
Therapeutics | News | 0 Comment | 07 Apr, 2022
A new study led by Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisati...Read more
-
Rona Therapeutics raises $33 million in Series A
Therapeutics | News | 0 Comment | 07 Apr, 2022
China-based startup Rona Therapeutics announces the successful completion of $33 million Series A financing to advance p...Read more
-
Hong Kong highlights significant global incidence of newly diagnosed type 1 diabetes
Therapeutics | News | 0 Comment | 06 Apr, 2022
One of the largest global studies of its kind, led by The Chinese University of Hong Kong (CUHK)’s Faculty of Medi...Read more
-
Australia launches flagship biological storage facility 'Biobanking Victoria'
Therapeutics | News | 0 Comment | 06 Apr, 2022
Monash University has officially launched Australia’s first industry-focused storage facility for biological mater...Read more
-
Exploring the Possibilities of RNA Therapeutics
Therapeutics | News | By Ayesha Siddiqui | 0 Comment | 02 Apr, 2022
The success of the mRNA vaccine against COVID-19 has skyrocketed the development of RNA therapies. In 2021, more than 60...Read more
-
CHA Medical & Bio Group opens new cell gene biobank facility in Korea
Therapeutics | News | 0 Comment | 31 Mar, 2022
CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea...Read more
-
Taiwan accepts CANbridge's NDA for Alagille Syndrome
Therapeutics | News | 0 Comment | 29 Mar, 2022
CANbridge Pharmaceuticals Inc. has announced that the Taiwan Food and Drug Administration (TFDA) has accepted the New Dr...Read more
